HHMI researchers have developed a potential TB vaccine that completely eliminates tuberculosis bacteria from infected tissues in some mice.
Scientists have found several new ways to kill M. tuberculosis, which could lead to the development of alternative drugs.
Researchers have produced a genetically altered strain of tuberculosis that elicits a stronger immune response than the current vaccine.
A handful of Pittsburgh high school and college students who isolated and characterized 30 new viruses that infect bacteria have co-authored a research article in a peer-reviewed scientific journal.
HHMI researchers have identified a gene that enables mycobacteria to form biofilms.
HHMI and the Center for Strategic and International Studies convene a public symposium in Washington, D.C., on May 12, 2005 to discuss the alarming spread of HIV and TB.
HHMI researchers unearth a treasure trove of genomic information from ten newly identified viruses found in the monkey pit at the Bronx Zoo and other locations.
Investigadores del HHMI han desenterrado un tesoro de información genómica contenido en diez virus recientemente identificados que fueron encontrados en la fosa de los monos del Zoológico del Bronx y en otros lugares.
An enzyme that allows the TB bacterium to metabolize nutrients and persist for months may be a good target for the next generation of TB drugs.
Una enzima que le permite a la bacteria de la tuberculosis metabolizar nutrientes y persistir por meses, podría ser un buen blanco de ataque para la próxima generación de drogas contra la tuberculosis.
Researchers have created a mutant strain of TB that fails to establish a lethal chronic infection in mice.
Investigadores han creado una cepa mutante de TB que no puede establecer una infección crónica y mortal en ratones.
More than one in three people on the planet have tuberculosis (TB). HHMI investigators have pinpointed a weak spot in the bacterium that causes TB.